Caffeine, MitoQ, and GABA Prophylaxis of Mitochondrial Dysfunction Induced in Human Pulmonary Cells by Normobaric-Hyperoxia and Hyperbaric-Hyperoxia | Canada Hyperbarics Skip to main content
Study Oxid Med Cell Longev 2025

Caffeine, MitoQ, and GABA Prophylaxis of Mitochondrial Dysfunction Induced in Human Pulmonary Cells by Normobaric-Hyperoxia and Hyperbaric-Hyperoxia

Hossain T, Secor J, Eckmann D — Oxid Med Cell Longev, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers quantified the prophylactic effects of caffeine, MitoQ, and γ-aminobutyric acid (GABA) in protecting human pulmonary cells in vitro from mitochondrial alterations induced by normobaric- and hyperbaric-hyperoxic conditions.

What They Found

Exposure to hyperoxia induced pulmonary oxygen toxicity, altering mitochondrial dynamics and bioenergetics in human pulmonary cells. The drugs caffeine, MitoQ, and GABA resulted in differential effects on hyperoxia-induced alterations in cellular respiration function, stability of mitochondrial potential, and distribution of ATP-linked respiration, with various mitochondrial parameters such as motility, intracellular distribution, and size being measured.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A primary limitation is that this study was conducted in vitro using cultured human pulmonary cells, which may not fully translate to complex physiological conditions in living organisms.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 41031329
Year Published 2025
Journal Oxid Med Cell Longev
MeSH Terms Humans; Organophosphorus Compounds; Mitochondria; gamma-Aminobutyric Acid; Caffeine; Hyperoxia; Ubiquinone; Lung; Membrane Potential, Mitochondrial; A549 Cells; Hyperbaric Oxygenation

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.